es4

Methodology Services for Rare Disease Research

Designing clinical studies for rare diseases comes with unique challenges. Each patient often contributes a rich and complex medical story but the number of patients is small. This leads to data that are diverse, detailed, and sometimes incomplete. To turn this complexity into scientific strength, we provide advanced methodological support for researchers across Europe .

By bringing together specialists in biostatistics, epidemiology, data science, artificial intelligence, and machine learning, we aim to empower clinical research networks and healthcare centres with the best tools to conduct high-quality studies in rare diseases.​

Our goal is to turn complex data into clear answers that benefit patients living with rare diseases.​

How We Work With You

We offer hands-on expertise directly to research teams within ERDERA or with funded projects conducting clinical trials or working with real-world evidence. We also work closely with regulatory specialists to explore qualification pathways for innovative methods, helping them gain recognition and adoption across Europe. Get in touch with us for additional information.

What We Do

Our teams across different institutions in Europe help research groups choose and apply the most suitable study designs and statistical methods for rare disease research.

We support projects using:

  • Clinical trials
  • Real-World Data, including registries and epidemiological studies
  • Mixed data sources, combining clinical and real-world evidence

We use a wide range of cutting-edge methods such as Bayesian and likelihood-based approaches, randomization techniques, and modern comparison tools, to ensure analyses are robust, precise and tailored to small populations.

Why It Matters

Over the past decade, European collaborations have shown that adapted methodologies dramatically improve the value of clinical studies for rare diseases. Building on this strong foundation, our service accelerates:

  • The implementation of proven methods developed specifically for small populations
  • The development of new approaches where gaps and unmet needs remain

This helps ensure that promising innovations reach clinical teams and patients more efficiently.

Relevant Publications and Resources

A new simulation framework leverages pharmacometrics to optimise clinical trial designs for disease-modifying treatments in rare neurological conditions.
Experts provide a comprehensive reflection on the unique clinical and methodological challenges inherent in designing and executing trials for rare diseases.
Analysis of registry data offers critical insights into the progression of seizures and speech development in patients with Dravet syndrome.

Explore connected resources via an interactive interface that visually represents relationships between datasets, samples, and research projects.

FAQ Section

Useful when looking for something specific or attempting to navigate processes.

Contact the Methodoloy Services

Get in touch with our pool of experts.

You might also be interested in

The RealiseD project launched a new multi-stakeholder survey that invites the rare disease community to share insights and help improve clinical trial enrolment
The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.
13 January – 10 February 2026 | Online webinar series to advance best practices in clinical trial design for rare and ultra rare diseases.
EMA seeks stakeholder input on new reflection paper to reduce and replace non‑human primate use in medicines safety testing through 3Rs approaches.